299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details


臨床試験数 : 1,696 薬物数 : 1,644 - (DrugBank : 272) / 標的遺伝子数 : 96 - 標的パスウェイ数 : 170

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01684410
(ClinicalTrials.gov)
August 20126/9/2012Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic FibrosisA Three Week Dose Escalation, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of 100 mg or 200 mg of Inhaled Alpha-1 HC, Once a Day in Subjects With Cystic Fibrosis.Cystic FibrosisBiological: Alpha-1 HC 100 mg;Biological: Placebo;Biological: Alpha-1 HC 200 mgGrifols Therapeutics Inc.NULLCompleted18 YearsN/AAll30Phase 2United States
2NCT00486837
(ClinicalTrials.gov)
December 200313/6/2007Deposition of Inhaled Prolastin in Cystic Fibrosis PatientsMulticenter, Randomized, Parallel Group Study to Investigate the Optimal Deposition Site for Inhaled Prolastin® in Patients With Cystic Fibrosis (CF)Cystic FibrosisDrug: Alpha1-Proteinase Inhibitor (Human)Grifols Therapeutics Inc.NULLCompleted8 YearsN/AAll72Phase 2NULL